Association Between Coronary Assessment in Heart Failure and Clinical Outcomes Within a Safety-Net Setting Using a Target Trial Emulation Observational Design.

Autor:	Durstenfeld MS; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF)., Thakkar A; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF)., Ma Y; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF)., Zier LS; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF)., Davis JD; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF)., Hsue PY; Division of Cardiology at Zuckerberg San Francisco General and Department of Medicine, University of California, San Francisco (UCSF).
Jazyk:	angličtina
Zdroj:	Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2024 Jun; Vol. 17 (6), pp. e010800. Date of Electronic Publication: 2024 Apr 29.
DOI:	10.1161/CIRCOUTCOMES.123.010800
Abstrakt:	Background: Ischemic cardiomyopathy is the leading cause of heart failure (HF). Most patients do not undergo coronary assessment after HF diagnosis. There are no randomized clinical trials of coronary assessment after HF diagnosis. Methods: Using an electronic health record cohort of all individuals with HF within the San Francisco Health Network from 2001 to 2019, we identified factors associated with coronary assessment. Then, we studied the association of coronary assessment within 30 days of HF diagnosis with all-cause mortality and a composite of mortality and emergent angiography using a target trial emulation observational comparative-effectiveness approach. Target trial emulation is an approach to causal inference based on creating a hypothetical randomized clinical trial protocol and using observational data to emulate the protocol. We used propensity scores for covariate adjustment. We used national death records to improve the ascertainment of mortality and included falsification end points for the cause of death. Results: Among 14 829 individuals with HF (median, 62 years old; 5855 [40%] women), 3987 (26.9%) ever completed coronary assessment, with 2467/13 301 (18.5%) with unknown coronary artery disease status at HF diagnosis assessed. Women, older individuals, and people without stable housing were less likely to complete coronary assessment. Among 5972 eligible persons of whom 627 underwent early elective coronary assessment, coronary assessment was associated with lower mortality (hazard ratio, 0.84 [95% CI, 0.72-0.97]; P =0.025), reduced risk of the composite outcome (hazard ratio, 0.86 [95% CI, 0.73-1.00]), higher rates of revascularization (odds ratio, 7.6 [95% CI, 5.4-10.6]), and higher use of medical therapy (odds ratio, 2.5 [95% CI, 1.7-3.6]), but not the falsification end points. Conclusions: In a safety-net population, disparities in coronary assessment after HF diagnosis are not fully explained by coronary artery disease risk factors. Early coronary assessment is associated with improved HF outcomes possibly related to higher rates of revascularization and guideline-directed medical therapy but with low certainty that this finding is not attributable to unmeasured confounding. Competing Interests: Disclosures None.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu